184 related articles for article (PubMed ID: 21562916)
21. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
[TBL] [Abstract][Full Text] [Related]
22. MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro.
Zhou W; Li X; Liu F; Xiao Z; He M; Shen S; Liu S
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):838-46. PubMed ID: 23017832
[TBL] [Abstract][Full Text] [Related]
23. Upregulated CNTN1 is associated with lymph node metastasis and poor prognosis of colorectal cancer.
Li G; Zhang Z; Ge G; Fang K; Zhu J
Cancer Biomark; 2021; 30(2):193-201. PubMed ID: 33104020
[TBL] [Abstract][Full Text] [Related]
24. Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients.
Yu D; Li Z; Gan M; Zhang H; Yin X; Tang S; Wan L; Tian Y; Zhang S; Zhu Y; Lai M; Zhang D
Tumour Biol; 2015 Nov; 36(11):8531-5. PubMed ID: 26032091
[TBL] [Abstract][Full Text] [Related]
25. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
26. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
Wang LL; Du LT; Li J; Liu YM; Qu AL; Yang YM; Zhang X; Zheng GX; Wang CX
World J Gastroenterol; 2014 Aug; 20(32):11340-6. PubMed ID: 25170220
[TBL] [Abstract][Full Text] [Related]
27. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
28. High expression of CASK correlates with progression and poor prognosis of colorectal cancer.
Wei JL; Fu ZX; Fang M; Zhou QY; Zhao QN; Guo JB; Lu WD; Wang H
Tumour Biol; 2014 Sep; 35(9):9185-94. PubMed ID: 24927672
[TBL] [Abstract][Full Text] [Related]
29. Aberrant expression of stress-induced phosphoprotein 1 in colorectal cancer and its clinicopathologic significance.
Zhang Z; Ren H; Yang L; Zhang X; Liang W; Wu H; Huang L; Kang J; Xu J; Zhai E; Cai S; He Y
Hum Pathol; 2018 Sep; 79():135-143. PubMed ID: 29879402
[TBL] [Abstract][Full Text] [Related]
30. [Expression of microRNA-152 in colorectal cancer and its relationship with prognosis].
Wang Y; Yuan W; Ma X; Ma J
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):763-766. PubMed ID: 27784461
[No Abstract] [Full Text] [Related]
31. Expression and clinical significance of absent in melanoma 2 in colorectal cancer.
Zhang Z; Dong X; Yang X; Wan D; Sun L; Gu M; Li M; Zhu Z; Wang J; Shang Z; He S
Biomed Pharmacother; 2017 Oct; 94():843-849. PubMed ID: 28802238
[TBL] [Abstract][Full Text] [Related]
32. Gab2 is a novel prognostic factor for colorectal cancer patients.
Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
[TBL] [Abstract][Full Text] [Related]
33. High expression of ROR2 in cancer cell correlates with unfavorable prognosis in colorectal cancer.
Mei H; Lian S; Zhang S; Wang W; Mao Q; Wang H
Biochem Biophys Res Commun; 2014 Oct; 453(4):703-9. PubMed ID: 25301559
[TBL] [Abstract][Full Text] [Related]
34. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
35. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
36. Aberrant expression of Rab1A and its prognostic significance in human colorectal cancer.
Wang ZK; Cheng ZW; Chen SJ; Zhu XG; Gu YP; Yang XD; Sun L; Liu WT; Zhang YJ; Yuan JF; Tian KJ; Yao YZ; He SB
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4509-4517. PubMed ID: 30058685
[TBL] [Abstract][Full Text] [Related]
37. Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma.
Du P; Wang S; Tang X; An C; Yang Y; Jiang WG
Anticancer Res; 2017 Aug; 37(8):4499-4505. PubMed ID: 28739745
[TBL] [Abstract][Full Text] [Related]
38. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of Wnt7α protein predicts poor survival in patients with colorectal carcinoma.
Wang Y; Wei J; Zhang S; Li G; Zhang T; Yu X; Chen H; Liu M
Tumour Biol; 2015 Nov; 36(11):8781-7. PubMed ID: 26055144
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer.
Likui W; Hong W; Shuwen Z
J Gastrointest Surg; 2010 Jan; 14(1):74-81. PubMed ID: 19763701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]